{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:10:58Z","timestamp":1785244258808,"version":"3.55.0"},"reference-count":11,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.1182\/bloodadvances.2025017086","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:31:50Z","timestamp":1757431910000},"page":"4526-4527","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Multifaceted cfDNA profiling in mantle cell lymphoma"],"prefix":"10.1182","volume":"9","author":[{"given":"Brian J.","family":"Sworder","sequence":"first","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-7415","authenticated-orcid":false,"given":"Alex F.","family":"Herrera","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2025090911314091100_bib1","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1182\/bloodadvances.2025015791","article-title":"Circulating tumor DNA determinants of response and outcome in relapsed\/refractory mantle cell lymphoma","volume":"9","author":"Meriranta","year":"2025","journal-title":"Blood Adv"},{"issue":"12","key":"2025090911314091100_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood.2021014270","article-title":"Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma","volume":"140","author":"Ferrero","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2025090911314091100_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clml.2023.12.006","article-title":"Immunoglobulin high throughput sequencing (Ig-HTS) minimal residual disease (MRD) analysis is an effective surveillance tool in patients with mantle cell lymphoma","volume":"24","author":"Rezazadeh","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"36","key":"2025090911314091100_bib4","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","article-title":"Detection of ultra-rare mutations by next-generation sequencing","volume":"109","author":"Schmitt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2025090911314091100_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/bloodadvances.2023011920","article-title":"MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial","volume":"8","author":"Jerkeman","year":"2024","journal-title":"Blood Adv"},{"issue":"28","key":"2025090911314091100_bib6","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025090911314091100_bib7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/bloodadvances.2021006415","article-title":"Risk profiling of patients with relapsed\/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA","volume":"6","author":"Herrera","year":"2022","journal-title":"Blood Adv"},{"issue":"12","key":"2025090911314091100_bib8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41587-021-00981-w","article-title":"Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA","volume":"39","author":"Kurtz","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"364","key":"2025090911314091100_bib9","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7","key":"2025090911314091100_bib10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/bloodadvances.2024014136","article-title":"Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels","volume":"9","author":"Moia","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"2025090911314091100_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccell.2022.12.005","article-title":"Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas","volume":"41","author":"Sworder","year":"2023","journal-title":"Cancer Cell"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4526\/2411389\/blooda_adv-2025-017086-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4526\/2411389\/blooda_adv-2025-017086-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:31:51Z","timestamp":1757431911000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/17\/4526\/547134\/Multifaceted-cfDNA-profiling-in-mantle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":11,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017086","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,9]]},"published":{"date-parts":[[2025,9,9]]}}}